Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Soucek

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Cancer Cell|July 19, 2002
Myc-Is this the oncogene from Hell?Laura Soucek, Gerard Evan
Current Opinion in Pharmacology|July 2, 2019
Editorial overview: Peptides in cancerJonathan Whitfield, Laura Soucek
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
An "-omycs" Toolbox to Work with MYCJonathan Whitfield, Laura Soucek
Nature Reviews. Drug Discovery|February 19, 2025
MYC in cancer: from undruggable target to clinical trialsJonathan R Whitfield, Laura Soucek
Cellular and Molecular Life Sciences : CMLS|October 29, 2011
Tumor microenvironment: becoming sick of MycJonathan R Whitfield, Laura Soucek
Current Opinion in Genetics & Development|December 8, 2009
The ups and downs of Myc biologyLaura Soucek, Gerard I Evan
Cells|April 9, 2020
Blocking Myc to Treat Cancer: Reflecting on Two Decades of OmomycDaniel Massó-Vallés, Laura Soucek
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
The Myc world within reachNicole M Sodir, Laura Soucek
The Journal of Cell Biology|June 23, 2021
The long journey to bring a Myc inhibitor to the clinicJonathan R Whitfield, Laura Soucek
Translational Cancer Research|October 4, 2019
Myc and Ras, the Bonnie and Clyde of immune evasionSílvia Casacuberta-Serra, Laura Soucek
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Cancer Cell|July 19, 2002
Myc-Is this the oncogene from Hell?Laura Soucek, Gerard Evan
Current Opinion in Pharmacology|July 2, 2019
Editorial overview: Peptides in cancerJonathan Whitfield, Laura Soucek
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
An "-omycs" Toolbox to Work with MYCJonathan Whitfield, Laura Soucek
Nature Reviews. Drug Discovery|February 19, 2025
MYC in cancer: from undruggable target to clinical trialsJonathan R Whitfield, Laura Soucek
Cellular and Molecular Life Sciences : CMLS|October 29, 2011
Tumor microenvironment: becoming sick of MycJonathan R Whitfield, Laura Soucek
Current Opinion in Genetics & Development|December 8, 2009
The ups and downs of Myc biologyLaura Soucek, Gerard I Evan
Cells|April 9, 2020
Blocking Myc to Treat Cancer: Reflecting on Two Decades of OmomycDaniel Massó-Vallés, Laura Soucek
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
The Myc world within reachNicole M Sodir, Laura Soucek
The Journal of Cell Biology|June 23, 2021
The long journey to bring a Myc inhibitor to the clinicJonathan R Whitfield, Laura Soucek
Translational Cancer Research|October 4, 2019
Myc and Ras, the Bonnie and Clyde of immune evasionSílvia Casacuberta-Serra, Laura Soucek
Pageof 8